79 related articles for article (PubMed ID: 19714520)
1. [Effects of erdosteine on inflammation and fibrosis in rats with pulmonary fibrosis induced by bleomycin].
Karapolat S
Tuberk Toraks; 2009; 57(2):244-5; author reply 245-6. PubMed ID: 19714520
[No Abstract] [Full Text] [Related]
2. [Effects of erdosteine on inflammation and fibrosis in rats with pulmonary fibrosis induced by bleomycin].
Erden ES; Kirkil G; Deveci F; Ilhan N; Cobanoğlu B; Turgut T; Muz MH
Tuberk Toraks; 2008; 56(2):127-38. PubMed ID: 18701972
[TBL] [Abstract][Full Text] [Related]
3. Erdosteine prevents bleomycin-induced pulmonary fibrosis in rats.
Sogut S; Ozyurt H; Armutcu F; Kart L; Iraz M; Akyol O; Ozen S; Kaplan S; Temel I; Yildirim Z
Eur J Pharmacol; 2004 Jun; 494(2-3):213-20. PubMed ID: 15212977
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of bleomycin-induced lung fibrosis by oral sulfhydryl containing antioxidants in rats: erdosteine and N-acetylcysteine.
Yildirim Z; Kotuk M; Iraz M; Kuku I; Ulu R; Armutcu F; Ozen S
Pulm Pharmacol Ther; 2005; 18(5):367-73. PubMed ID: 15939316
[TBL] [Abstract][Full Text] [Related]
5. Effects of erdosteine on bleomycin-induced lung fibrosis in rats.
Boyaci H; Maral H; Turan G; Başyiğit I; Dillioğlugil MO; Yildiz F; Tugay M; Pala A; Erçin C
Mol Cell Biochem; 2006 Jan; 281(1-2):129-37. PubMed ID: 16328965
[TBL] [Abstract][Full Text] [Related]
6. The protective effect of erdosteine against cyclosporine A-induced cardiotoxicity in rats.
Selcoki Y; Uz E; Bayrak R; Sahin S; Kaya A; Uz B; Karanfil A; Ozkara A; Akcay A
Toxicology; 2007 Sep; 239(1-2):53-9. PubMed ID: 17689165
[TBL] [Abstract][Full Text] [Related]
7. [ Erdosteine (Mucodox), oral administration].
J Pharm Belg; 2011 Jun; (2):55-6. PubMed ID: 21823444
[No Abstract] [Full Text] [Related]
8. Effects of aminoguanidine and antioxidant erdosteine on bleomycin-induced lung fibrosis in rats.
Yildirim Z; Turkoz Y; Kotuk M; Armutcu F; Gurel A; Iraz M; Ozen S; Aydogdu I; Akyol O
Nitric Oxide; 2004 Sep; 11(2):156-65. PubMed ID: 15491848
[TBL] [Abstract][Full Text] [Related]
9. Erdosteine for COPD exacerbations.
Drug Ther Bull; 2008 Oct; 46(10):79-80. PubMed ID: 18832259
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats.
Fadillioğlu E; Erdoğan H; Söğüt S; Kuku I
J Appl Toxicol; 2003; 23(1):71-4. PubMed ID: 12518339
[TBL] [Abstract][Full Text] [Related]
11. Erdosteine ameliorates neurological outcome and oxidative stress due to ischemia/reperfusion injury in rabbit spinal cord.
Ege E; Ilhan A; Gurel A; Akyol O; Ozen S
Eur J Vasc Endovasc Surg; 2004 Oct; 28(4):379-86. PubMed ID: 15350559
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study).
Marchioni CF; Polu JM; Taytard A; Hanard T; Noseda G; Mancini C
Int J Clin Pharmacol Ther; 1995 Nov; 33(11):612-8. PubMed ID: 8688986
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E
J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
[TBL] [Abstract][Full Text] [Related]
14. Protective role of erdosteine pretreatment on oleic acid-induced acute lung injury.
Erdem A; Gedikli E; Yersal N; Karaismailoglu S; Muftuoglu S; Fadillioglu E; Tuncer M
J Surg Res; 2017 Jun; 213():234-242. PubMed ID: 28601320
[TBL] [Abstract][Full Text] [Related]
15. Erdosteine.
Dechant KL; Noble S
Drugs; 1996 Dec; 52(6):875-81; discussion 882. PubMed ID: 8957158
[TBL] [Abstract][Full Text] [Related]
16. Erdosteine ameliorates lung injury induced by transient aortic occlusion in rats.
Kurtoglu T; Sacar M; Inan BK; Duver MH; Guler A; Ucak A; Us MH; Yilmaz AT
Cardiovasc J Afr; 2007; 18(6):367-70. PubMed ID: 18092111
[TBL] [Abstract][Full Text] [Related]
17. Erdosteine: its relevance in COPD treatment.
Moretti M
Expert Opin Drug Metab Toxicol; 2009 Mar; 5(3):333-43. PubMed ID: 19331595
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: a 15-day, prospective, parallel, open-label, pilot study.
Crisafulli E; Coletti O; Costi S; Zanasi E; Lorenzi C; Lucic S; Fabbri LM; Bertini M; Clini EM
Clin Ther; 2007 Sep; 29(9):2001-9. PubMed ID: 18035199
[TBL] [Abstract][Full Text] [Related]
19. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
20. The effects of erdosteine, N-acetylcysteine, and vitamin E on nicotine-induced apoptosis of pulmonary cells.
Demiralay R; Gürsan N; Erdem H
Toxicology; 2006 Feb; 219(1-3):197-207. PubMed ID: 16377052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
